Skip to main content

SeaSpine Holdings Corporation (SPNE)

NASDAQ: SPNE · IEX Real-Time Price · USD
14.98
+0.29 (1.97%)
After-hours:Oct 25, 2021 5:54 PM EDT
14.69
-0.14 (-0.94%)
At close: Oct 25, 4:00 PM
Market Cap534.69M
Revenue (ttm)179.06M
Net Income (ttm)-34.85M
Shares Out33.49M
EPS (ttm)-1.20
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume130,960
Open14.92
Previous Close14.83
Day's Range14.54 - 15.10
52-Week Range12.43 - 22.97
Beta1.20
AnalystsStrong Buy
Price Target26.89 (+83.0%)
Est. Earnings DateNov 9, 2021

About SPNE

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products include demineralized bone matrices (DBM), collagen ceramic matrices, demineralized cancellous allograft bone ...

IndustryHealth Care Equipment & Supplies
CEOKeith Valentine
Employees421
Stock ExchangeNASDAQ
Ticker SymbolSPNE
Full Company Profile

Financial Performance

In 2020, SPNE's revenue was $154.35 million, a decrease of -2.98% compared to the previous year's $159.08 million. Losses were -$43.18 million, 9.94% more than in 2019.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for SPNE stock is "Strong Buy." The 12-month stock price forecast is 26.89, which is an increase of 83.05% from the latest price.

Price Target
$26.89
(83.05% upside)
Analyst Consensus: Strong Buy

News

SeaSpine to Report Third Quarter 2021 Financial Results on October 28, 2021

CARLSBAD, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

5 days ago - GlobeNewsWire

SeaSpine Announces Full Commercial Launch of The NorthStar OCT Posterior Cervical Fixation System

CARLSBAD, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

2 weeks ago - GlobeNewsWire

SeaSpine Announces First Cases of 7D Surgical Percutaneous Spine Module for Minimally Invasive Surgery

CARLSBAD, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

2 weeks ago - GlobeNewsWire

SeaSpine® Receives Innovative Technology Contract from Vizient for its 7D FLASH™ Navigation System

Contract awarded for products that potentially bring improvement to health care industry Contract awarded for products that potentially bring improvement to health care industry

3 weeks ago - GlobeNewsWire

SeaSpine Announces CE Mark Certification of 7D Surgical Cranial Module and Percutaneous Spine Module for Minimally In...

CARLSBAD, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

4 weeks ago - GlobeNewsWire

SeaSpine Warns Surgical Revenue To Be Hit By COVID-19

SeaSpine Holdings Corp (NASDAQ: SPNE) is the latest medical device maker warning that the SARS-CoV-2 Delta variant wave is hurting its business. The Company filed an update for investors with the SEC, c...

4 weeks ago - Benzinga

5 Stocks to Deflect Delta Variant Curveball From Orthopedic Space

OrthoPediatrics (KIDS), Orthofix (OFIX), Zimmer Biomet (ZBH), Stryker (SYK) and SeaSpine (SPNE) are expected to hold ground despite a challenging business climate.

Other symbols:KIDSNUVAOFIXSYKZBH
1 month ago - Zacks Investment Research

SeaSpine to Participate in the Cantor Virtual Global Healthcare Conference

CARLSBAD, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

1 month ago - GlobeNewsWire

SeaSpine to Host Analyst & Investor Event on September 30, 2021

CARLSBAD, Calif., Sept. 16, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

1 month ago - GlobeNewsWire

SeaSpine Announces Initial Launch of Mariner Adult Deformity System

CARLSBAD, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

1 month ago - GlobeNewsWire

SeaSpine Announces Limited Commercial Launch of the WaveForm® A (ALIF) 3D-Printed Interbody System

CARLSBAD, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

2 months ago - GlobeNewsWire

3 Stocks Growing Earnings Fast

The S&P 500 saw its trailing 12-month real earnings per share increase by a compound annual growth rate of nearly 6% over the past five years. The index's share price ($4,447.70 as of Wednesday) has gro...

Other symbols:HUBB
2 months ago - GuruFocus

SeaSpine Reports Granting of Inducement Awards

CARLSBAD, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

2 months ago - GlobeNewsWire

SeaSpine Beats Street In Q2 On Higher Sales From Spinal Implants, Orthobiologics; Raises FY2021 Sales Outlook

SeaSpine Holdings Corporation (NASDAQ: SPNE) posted a narrower than expected second-quarter EPS loss of $(0.16), beating the consensus forecast of $(0.32) and lower than $(0.50) posted a year ago. Sales...

2 months ago - Benzinga

SeaSpine Holdings (SPNE) Reports Q2 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of 2.86% and 2.94%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

SeaSpine Holdings: Q2 Earnings Insights

Shares of SeaSpine Holdings (NASDAQ:SPNE) moved higher in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 68.00% over the past year to ($0.16), w...

2 months ago - Benzinga

SeaSpine Reports Second Quarter 2021 Financial Results

Announces Record Quarterly Revenue

2 months ago - GlobeNewsWire

SeaSpine to Participate in the Canaccord Genuity 41st Annual Growth Conference

CARLSBAD, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

2 months ago - GlobeNewsWire

Will SeaSpine Holdings (SPNE) Report Negative Q2 Earnings? What You Should Know

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

SeaSpine to Report Second Quarter 2021 Financial Results on August 2, 2021

CARLSBAD, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

2 months ago - GlobeNewsWire

SeaSpine Stock Is Trading Higher On FDA Approval For 7D Surgical Spine Module

The FDA has given 510(k) clearance to SeaSpine Holdings Corporation's (NASDAQ:SPNE) 7D Percutaneous Spine Module for minimally invasive surgery.  This news follows SeaSpine's recent acquisition of 7D Su...

3 months ago - Benzinga

SeaSpine Announces FDA 510(k) Clearance of 7D Surgical Percutaneous Spine Module for Minimally Invasive Surgery

CARLSBAD, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

3 months ago - GlobeNewsWire

SeaSpine to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference

CARLSBAD, Calif., June 29, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

3 months ago - GlobeNewsWire

SeaSpine Announces Limited Commercial Launch of the WaveForm® L (Lateral) 3D-Printed Interbody System

CARLSBAD, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

4 months ago - GlobeNewsWire

SeaSpine Reports Granting of Inducement Awards

CARLSBAD, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

4 months ago - GlobeNewsWire